Cibacen 5 mg Film Coated Tablet

Țară: Irlanda

Limbă: engleză

Sursă: HPRA (Health Products Regulatory Authority)

Cumpara asta acum

Descarcare Prospect (PIL)
12-05-2021

Ingredient activ:

Benazepril hydrochloride

Disponibil de la:

Mylan IRE Healthcare Limited

Codul ATC:

C09AA; C09AA07

INN (nume internaţional):

Benazepril hydrochloride

Dozare:

5 milligram(s)

Forma farmaceutică:

Film-coated tablet

Tip de prescriptie medicala:

Product subject to prescription which may be renewed (B)

Zonă Terapeutică:

ACE inhibitors, plain; benazepril

Statutul autorizaţiei:

Not marketed

Data de autorizare:

1999-06-16

Prospect

                                PACKAGE LEAFLET
PACKAGE LEAFLET: INFORMATION FOR THE USER
CIBACEN 5MG
FILM COATED TABLETS
Benazepril hydrochloride
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor or pharmacist.
-
This medicine has been prescribed for you. Do not pass it on to
others. It may harm them,
even if their symptoms are the same as yours.
-
If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side
effects not listed in this leaflet. See section 4.
IN THIS LEAFLET:
1.
What Cibacen is and what it is used for
2.
What you need to know before you take Cibacen
3.
How to take Cibacen
4.
Possible side effects
5.
How to store Cibacen
6.
Contents of the pack and other information
1.
WHAT CIBACEN IS AND WHAT IT IS USED FOR
Cibacen film-coated tablets contain 5mg benazepril hydrochloride. This
is one of a group of
medicines called ACE inhibitors. Cibacen is used to treat high blood
pressure. It can also be
used to treat some types of heart or kidney disease.
2.
WHAT YOU NEED TO KNOW BEFORE YOU TAKEN CIBACEN
DO NOT TAKE CIBACEN

If you are allergic to benazepril or any other ACE inhibitor or to any
of the
ingredients in the tablets (listed in section 6)

If you previously had a reaction to an ACE inhibitor involving
hoarseness, swelling of
the face, mouth, hands or feet, or sudden breathing problems

If you have diabetes or impaired kidney function and you are treated
with a blood
pressure lowering medicine containing aliskiren.

If you are more than 3 months pregnant. (it is also better to avoid
Cibacen in early
pregnancy – see pregnancy section).
WARNINGS AND PRECAUTIONS
Talk to your doctor or pharmacist before taking Cibacen
If you are taking any of the following medicines used to treat high
blood pressure:
–
An angiotensin II receptor blocker (ARBs) (also known as sartans –
for example,
valsartan, telmisartan, irb
                                
                                Citiți documentul complet
                                
                            

Caracteristicilor produsului

                                Health Products Regulatory Authority
24 November 2020
CRN00C1SN
Page 1 of 12
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Cibacen 5 mg Film Coated Tablet
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 5mg benazepril hydrochloride.
Excipients: Each tablet contains 142mg lactose monohydrate
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Film coated tablets.
Light-yellow, ovaloid, slightly biconvex film-coated tablets scored on
both sides.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
In the treatment of hypertension as monotherapy or combined with other
antihypertensive agents (see sections 4.3, 4.4, 4.5
and 5.1).
As adjunctive therapy in patients with congestive heart failure.
Treatment of patients with mild-to-moderate progressive chronic renal
insufficiency (creatinine clearance 30-60 mL/min), with
the exception of those with polycystic kidney disease.
See sections 4.3, 4.4, 4.5 and 5.1.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
_ADULTS:Hypertension:_
The usual initial dosage is 10mg given as a single dose which may be
titrated to 20mg once daily if necessary. The dosage
should be adjusted according to blood pressure response, generally at
intervals of 1-2 weeks.
In some patients, the antihypertensive effect may diminish towards the
end of the dosing interval, and the total daily dosage
should then be divided into two equal doses.
The maximum recommended daily dose in hypertensive patients is 40mg,
given as a single dose or two doses.
If Cibacen alone does not produce a sufficient fall in blood pressure,
another antihypertensive drug eg. a thiazide-type diuretic
or calcium antagonist (initially at a low dose) may be added
concomitantly (see sections 4.3, 4.4, 4.5 and 5.1).
In the case of previous diuretic treatment the diuretic should be
discontinued for 2-3 days before commencing Cibacen and
reinstituted subsequently if necessary. If it is not possible to
discontinue the diuretic, the initial dose of Cibacen should be
reduced to 5mgin order to a
                                
                                Citiți documentul complet
                                
                            

Căutați alerte legate de acest produs